Clinical Trials Browser

Phase 2 × Sarcoma, Synovial × Ipilimumab × Clear all

NCT00140855 2022-10-12

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

Phase 2 Terminated

6 enrolled 8 charts

Sarcoma, Sarcoma, Synovial